Suppr超能文献

相似文献

1
Immune regulation by Tim-3.
F1000Res. 2018 Mar 14;7:316. doi: 10.12688/f1000research.13446.1. eCollection 2018.
2
Tumor-infiltrating Tim-3 T cells proliferate avidly except when PD-1 is co-expressed: Evidence for intracellular cross talk.
Oncoimmunology. 2016 Sep 22;5(10):e1200778. doi: 10.1080/2162402X.2016.1200778. eCollection 2016.
3
Tim-3, a negative regulator of anti-tumor immunity.
Curr Opin Immunol. 2012 Apr;24(2):213-6. doi: 10.1016/j.coi.2011.12.005. Epub 2012 Jan 4.
5
TIM-3, a promising target for cancer immunotherapy.
Onco Targets Ther. 2018 Oct 16;11:7005-7009. doi: 10.2147/OTT.S170385. eCollection 2018.
6
Characterization of age-associated exhausted CD8⁺ T cells defined by increased expression of Tim-3 and PD-1.
Aging Cell. 2016 Apr;15(2):291-300. doi: 10.1111/acel.12435. Epub 2016 Jan 10.
7
Tim-3 and Tim-4 as the potential targets for antitumor therapy.
Hum Vaccin Immunother. 2015;11(10):2458-62. doi: 10.1080/21645515.2015.1056953.
8
Tim-3 blocking rescue macrophage and T cell function against Mycobacterium tuberculosis infection in HIV+ patients.
J Int AIDS Soc. 2015 Oct 19;18(1):20078. doi: 10.7448/IAS.18.1.20078. eCollection 2015.
9
Manipulation of the Immune System for Cancer Defeat: A Focus on the T Cell Inhibitory Checkpoint Molecules.
Curr Med Chem. 2020;27(15):2402-2448. doi: 10.2174/0929867325666181106114421.

引用本文的文献

1
Immune cell exhaustion and apoptotic markers in major depressive disorder: Effects of in vitro cannabidiol administration.
Brain Behav Immun Health. 2025 Jul 19;48:101066. doi: 10.1016/j.bbih.2025.101066. eCollection 2025 Oct.
2
Tim-3 Promotes Early Differentiation of Tbet Effector T Cells During Acute Viral Infection.
bioRxiv. 2025 Jul 11:2025.07.08.663709. doi: 10.1101/2025.07.08.663709.
3
Negative Immune Checkpoint Inhibitors.
Pharmaceutics. 2025 May 28;17(6):713. doi: 10.3390/pharmaceutics17060713.
4
TIM proteins and microRNAs: distinct impact and promising interactions on transplantation immunity.
Front Immunol. 2024 Nov 22;15:1500228. doi: 10.3389/fimmu.2024.1500228. eCollection 2024.
7
Research progress and challenges of the PD-1/PD-L1 axis in gliomas.
Cell Biosci. 2024 Sep 27;14(1):123. doi: 10.1186/s13578-024-01305-6.
9
TIM-3 on myeloid cells promotes pulmonary inflammation through increased production of galectin-3.
Commun Biol. 2024 Sep 5;7(1):1090. doi: 10.1038/s42003-024-06762-w.

本文引用的文献

1
Tim-3 co-stimulation promotes short-lived effector T cells, restricts memory precursors, and is dispensable for T cell exhaustion.
Proc Natl Acad Sci U S A. 2018 Mar 6;115(10):2455-2460. doi: 10.1073/pnas.1712107115. Epub 2018 Feb 20.
3
Blockade of Tim-3 binding to phosphatidylserine and CEACAM1 is a shared feature of anti-Tim-3 antibodies that have functional efficacy.
Oncoimmunology. 2017 Nov 9;7(2):e1385690. doi: 10.1080/2162402X.2017.1385690. eCollection 2018.
5
TIM-3 Engagement Promotes Effector Memory T Cell Differentiation of Human Antigen-Specific CD8 T Cells by Activating mTORC1.
J Immunol. 2017 Dec 15;199(12):4091-4102. doi: 10.4049/jimmunol.1701030. Epub 2017 Nov 10.
6
Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor.
Nat Immunol. 2017 Dec;18(12):1332-1341. doi: 10.1038/ni.3868. Epub 2017 Oct 30.
7
Cutting Edge: Anti-TIM-3 Treatment Exacerbates Pulmonary Inflammation and Fibrosis in Mice.
J Immunol. 2017 Dec 1;199(11):3733-3737. doi: 10.4049/jimmunol.1700059. Epub 2017 Oct 23.
8
9
TIM-3: a crucial regulator of NK cells in pregnancy.
Cell Mol Immunol. 2017 Sep 11;14(11):948-50. doi: 10.1038/cmi.2017.85.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验